For questions about BMS medicines during this time please call 1-800-721-8909.

ONUREG® is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.

Close

Access and Support

Authorized distributors

The following distributors are authorized to sell ONUREG® and are able to service qualified accounts.

Authorized Distributor Network

Community Practices

Cardinal Health Specialty Pharmaceutical Distribution

Phone: 1-877-453-3972

https://specialtyonline.cardinalhealth.com
McKesson Specialty Health

Phone: 1-800-482-6700Fax: 1-800-289-9285

https://mscs.mckesson.com
Oncology Supply

Phone: 1-800-633-7555Fax: 1-800-248-8205

https://oncologysupply.com

Specialty Pharmacies and Institutions/Hospital Outpatient Facilities

ASD Healthcare

Phone: 1-800-746-6273Fax: 1-800-547-9413

https://www.asdhealthcare.com
Cardinal Health Specialty Pharmaceutical Distribution

Phone: 1-866-677-4844Fax: 1-614-553-6301

https://orderexpress.cardinalhealth.com
McKesson Plasma and Biologics

Phone: 1-877-625-2566Fax: 1-888-752-7626

https://connect.mckesson.com

Puerto Rico Hospitals and Oncology Clinics

Cardinal Puerto Rico

Phone: 1-787-625-4100Fax: 1-787-625-4398

https://www.cardinalhealth.pr
Cesar Castillo Inc.

Phone: 1-787-999-1616Fax: 1-787-999-1618

https://www.facilfarmaciacci.com

AML ICD-10-CM diagnosis codesa

ICD-10-CMcode

Descriptor

C92.00

Acute myeloblastic leukemia, not having achieved remission

C92.01

Acute myeloblastic leukemia, in remission

C92.50

Acute myelomonocytic leukemia, not having achieved remission

C92.51

Acute myelomonocytic leukemia, in remission

C92.60

Acute myeloid leukemia with 11q23-abnormality, not having achieved remission

C92.61

Acute myeloid leukemia with 11q23-abnormality, in remission

C92.A0

Acute myeloid leukemia with multilineage dysplasia, not having achieved remission

C92.A1

Acute myeloid leukemia with multilineage dysplasia, in remission

C92.Z0

Other myeloid leukemia, not having achieved remission

C92.Z1

Other myeloid leukemia, in remission

C92.90

Myeloid leukemia, unspecified, not having achieved remission

C92.91

Myeloid leukemia, unspecified, in remission

C93.00

Acute monoblastic/monocytic leukemia, not having achieved remission

C93.01

Acute monoblastic/monocytic leukemia, in remission

C94.00

Acute erythroid leukemia, not having achieved remission

C94.01

Acute erythroid leukemia, in remission

C94.20

Acute megakaryoblastic leukemia, not having achieved remission

C94.21

Acute megakaryoblastic leukemia, in remission

ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification.

aThese codes are not all-inclusive.

The information contained herein is not intended to provide specific coding and reimbursement advice for any specific patient or situation. You should check with your coding specialist to ensure appropriate submissions.

Product information

National Drug Codes (NDC) and packaging information

HCPCS code

Descriptor

10-digit NDC

11-digit NDCa

200 mg

Bottles of 14 with 2 desiccant canisters

59572-730-14

59572-0730-14

300 mg

Bottles of 14 with 2 desiccant canisters

59572-740-14

59572-0740-14

10-digit NDC

11-digit NDCa

59572-730-14

59572-0730-14

HCPCS code

Descriptor

300 mg

Bottles of 14 with 2 desiccant canisters

10-digit NDC

11-digit NDCa

59572-740-14

59572-0740-14

aThe red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.

Access and reimbursement resources to support your patients on ONUREG®

Three Simple Ways to Get Support

Contact your Access & Reimbursement Manager for general assistance and to schedule an office visit

Call Bristol Myers Squibb Access Support® at 1-800-861-0048, 8 am to 8 pm ET, Monday-Friday, to speak with a regionally assigned specialist

Visit www.BMSAccessSupport.com for information and resources, including the enrollment form, to help you and your patients with access to Bristol Myers Squibb products

Bristol Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement support services.